Form4insider filings, from the source

SEC Form 4 · accession 0001992324-26-000008

Dianthus Therapeutics, Inc. /DE/ · DNTH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Ryan Savitz
Officer — EVP, CFO & CBO
Period of report
Jul 9, 2026
Accepted (ET)
Jul 13, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001690585

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJul 9, 2026M31,249$21.77A31,249D
Common StockF2Jul 9, 2026S10,354$100.22D20,895D
Common StockF3Jul 9, 2026S15,329$101.24D5,566D
Common StockF4Jul 9, 2026S5,566$101.97D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F5$21.77Jul 9, 2026M31,249D—May 22, 2034Common Stock31,24968,751D

Explanation of responses